Loading…
Reported covered position: Legislative Director, Rep. Lucy McBath (2021-2022); Legislative Assistant, Rep. Lucy McBath (2019-2020); Legislative Aide, Sen. Brian Jones (2019); Legislative Correspondent, Sen. Brian Jones (2018-2019)
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: ALTRIA CLIENT SERVICES LLC · Firm: FORBES-TATE
Issues related to tobacco tax; Issues related to excise tax on tobacco in the Inflation Reduction Act of 2022 (PL 117-169); Issues related to drawback provision in H.R.1 - the One Big Beautiful Bill Act (PL 119-21).
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: ALTRIA CLIENT SERVICES LLC · Firm: FORBES-TATE
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
BREWERS ASSOCIATION via FORBES-TATE
2026 · third_quarter · 3T
Issues related to beer excise tax.
Issues related to beer excise tax.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
| LILLY USA, LLC |
| 17 |
| 2022–2026 |
| NOVARTIS, INC. | 17 | 2022–2026 |
| AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION | 16 | 2022–2026 |
| GENENTECH | 16 | 2022–2026 |
| IRON MOUNTAIN INFORMATION MANAGEMENT, LLC | 16 | 2022–2026 |
| PHRMA | 16 | 2022–2026 |
| ALEXION PHARMACEUTICALS, INC. | 15 | 2023–2026 |
| AUCTANE, INC. | 15 | 2023–2026 |
| GILEAD SCIENCES, INC. | 15 | 2022–2026 |
| NATIONAL PEST MANAGEMENT ASSOCIATION | 15 | 2022–2025 |
| TRACTOR SUPPLY CO. | 15 | 2023–2026 |
| TYSON SHARED SERVICES, INC. | 15 | 2023–2026 |
| LYKOS THERAPEUTICS | 14 | 2023–2025 |
| MERCK KGAA DARMSTADT GERMANY | 14 | 2024–2026 |
| AMERICAN INDEPENDENT MEDICAL PRACTICE ASSOCIATION | 13 | 2023–2026 |
| INDEPENDENT PHARMACY COOPERATIVE | 13 | 2023–2026 |
| INSURED RETIREMENT INSTITUTE | 13 | 2023–2026 |
| ASSOCIATION OF AMERICAN MEDICAL COLLEGES | 12 | 2024–2026 |
| HALOZYME THERAPEUTICS, INC. | 12 | 2023–2026 |
| AGLOGIC | 11 | 2024–2026 |
| CLARITEV (FKA MULTIPLAN CORPORATION) | 11 | 2024–2026 |
| INTERNATIONAL WOOD PRODUCTS ASSOCIATION | 10 | 2023–2025 |
| THE NATIONAL FOOTBALL LEAGUE PLAYERS ASSOCIATION | 10 | 2023–2025 |
| UBER TECHNOLOGIES INC. | 10 | 2024–2026 |
| CSL BEHRING | 9 | 2023–2025 |
| GINKGO BIOWORKS | 9 | 2023–2025 |
| REVANGENIX | 9 | 2024–2025 |
| COALITION FOR CANNABIS POLICY, EDUCATION, AND REGULATION | 8 | 2024–2026 |
| DIGESTIVE HEALTH PHYSICIANS ASSOCIATION | 8 | 2025–2026 |
| HEALTHY.IO (US), INC. | 8 | 2023–2025 |
| SOUTHEASTERN LUMBER MANUFACTURERS ASSOCIATION | 8 | 2025–2026 |
| ARGENTUM | 7 | 2022–2023 |
| BARILLA AMERICA INC. | 7 | 2024–2025 |
| HOMEWARD HEALTH | 7 | 2023–2024 |
| SCANSTAT | 7 | 2023–2024 |
| EMERGENT BIOSOLUTIONS | 6 | 2022–2023 |
| REGISTER AMERICA | 6 | 2025–2026 |
| SAFE AND ETHICAL PPE ACCESS ALLIANCE | 6 | 2024–2025 |
| TARSUS PHARMACEUTICALS | 6 | 2025–2026 |
| ULTRAGENYX PHARMACEUTICAL | 6 | 2022–2023 |
| VOTER REGISTRATION PROJECT | 6 | 2024–2025 |
| HERMEUS CORPORATION | 5 | 2022–2023 |
| HORIZON THERAPEUTICS | 5 | 2022–2023 |
| HOUSE RX | 5 | 2024–2025 |
| RED ANGUS ASSOCIATION OF AMERICA | 5 | 2025–2026 |
| THE CURE COALITION | 5 | 2025–2026 |
| VISION MANAGEMENT SERVICES GTI | 5 | 2025–2026 |
| CANN INC. | 4 | 2026 |
| COALITION FOR APP FAIRNESS | 4 | 2024–2025 |
| GRODAN INC. | 4 | 2025 |
| OFFICE OF THE COMMISSIONER OF BASEBALL D/B/A MAJOR LEAGUE BASEBALL | 4 | 2025–2026 |
| SK HYNIX NAND PRODUCT SOLUTIONS CORP. D/B/A/SOLIDIGM | 4 | 2022 |
| SUMRELL SUGG OBO CAROLINAEAST HEALTH SYSTEM | 4 | 2025–2026 |
| U.S. ANESTHESIA PARTNERS, INC. | 4 | 2023 |
| UNITED MUSCULOSKELETAL PARTNERS, LLC | 4 | 2023 |
| US Radiology Specialists, Inc. | 4 | 2023 |
| VIR BIOTECHNOLOGY, INC. | 4 | 2025–2026 |
| CONDUENT BUSINESS SERVICES, LLC | 3 | 2023–2024 |
| DENTSPLY SIRONA | 3 | 2025 |
| HD NURSING | 3 | 2023 |
| PARADIGM OPERATIONS LP | 3 | 2026 |
| ALTRIA CLIENT SERVICES LLC | 2 | 2026 |
| BREWERS ASSOCIATION | 2 | 2026 |
| CALIFORNIA LIFE SCIENCES ASSOCIATION | 2 | 2026 |
| DS ADMIRAL BIDCO, LLC | 2 | 2023 |
| I AM ALS | 2 | 2026 |
| JOHNSON & JOHNSON | 2 | 2026 |
| KALSHI INC. | 2 | 2026 |
| METRC LLC | 2 | 2025 |
| ORACLE | 2 | 2022–2023 |
| VEHO TECH, INC. | 2 | 2026 |
| AMGEN USA, INC. | 1 | 2026 |
| EYEPOINT PHARMACEUTICALS, INC. | 1 | 2022 |
| UNITED PARCEL SERVICE | 1 | 2023 |
Issues related to tobacco tax; Issues related to excise tax on tobacco in the Inflation Reduction Act of 2022 (PL 117-169); Issues related to drawback provision in H.R.1 - the One Big Beautiful Bill Act (PL 119-21).
Retirement Fairness for Charities and Educational Institutions Act of 2025
Client: INSURED RETIREMENT INSTITUTE · Firm: FORBES-TATE
Issues related to retirement savings; Issues related to H.R. 1013/S. 424 - The Retirement Fairness for Charities and Educational Institutions Act of 2025; Issues related to DOL Fiduciary rule.
Retirement Fairness for Charities and Educational Institutions Act of 2025
Client: INSURED RETIREMENT INSTITUTE · Firm: FORBES-TATE
Issues related to retirement savings; Issues related to H.R. 1013/S. 424 - The Retirement Fairness for Charities and Educational Institutions Act of 2025; Issues related to DOL Fiduciary rule; Issues related to the SECURE 2.0 Act (P.L. 117-328).
Retirement Fairness for Charities and Educational Institutions Act of 2025
Client: INSURED RETIREMENT INSTITUTE · Firm: FORBES-TATE
Issues related to retirement savings; Issues related to H.R. 1013/S. 424 - The Retirement Fairness for Charities and Educational Institutions Act of 2025; Issues related to DOL Fiduciary rule.
Issues related to prescription drug pricing; Issues related to Medicare, Medicaid, Cell and Gene Therapies; Issues regarding the 340B Drug Pricing Program; Issues related to the implementation of Consolidated Appropriations Act, 2024 (PL 118-42); Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); H.R. 1672 - Maintaining Investments in New Innovation Act; Issues related to Most Favored Nation policy; H.R. 3037 / S. 1500 Access to Breast Cancer Diagnosis Act of 2025.
Issues related to prescription drug pricing; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to pharmacy benefit managers; H.R. 1672 - Maintaining Investments in New Innovation Act; Issues related to the 340b program; Issues related to S. 832 - EPIC Act of 2025.
Issues related to prescription drug pricing; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to pharmacy benefit managers; H.R. 1672 - Maintaining Investments in New Innovation Act; Issues related to the 340b program; Issues related to S. 832 - EPIC Act of 2025.
Issues related to prescription drug pricing; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to pharmacy benefit managers; H.R. 1672 - Maintaining Investments in New Innovation Act; Issues related to the 340b program; Issues related to S. 832 - EPIC Act of 2025.
Issues related to prescription drug pricing; Issues related to Medicare, Medicaid, Cell and Gene Therapies; Issues regarding the 340B Drug Pricing Program; Issues related to the implementation of Consolidated Appropriations Act, 2024 (PL 118-42); Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); H.R. 1672 - Maintaining Investments in New Innovation Act; Issues related to Most Favored Nation policy; H.R. 3037/S. 1500 - Access to Breast Cancer Diagnosis Act of 2025.
Issues related to prescription drug pricing; Issues related to Medicare, Medicaid, Cell and Gene Therapies; Issues regarding the 340B Drug Pricing Program; Issues related to the implementation of Consolidated Appropriations Act, 2024 (PL 118-42); Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); H.R. 1672 - Maintaining Investments in New Innovation Act; Issues related to Most Favored Nation policy; H.R. 3037 / S. 1500 Access to Breast Cancer Diagnostic Act of 2025.
Issues related to prescription drug pricing; Issues related to Medicare, Medicaid, Cell and Gene Therapies; Issues regarding the 340B Drug Pricing Program; Issues related to the implementation of Consolidated Appropriations Act, 2024 (PL 118-42); Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); H.R. 1672 - Maintaining Investments in New Innovation Act; Issues related to Most Favored Nation policy; H.R. 3037/S. 1500 - Access to Breast Cancer Diagnosis Act of 2025.
Issues related to prescription drug pricing; Issues related to Medicare, Medicaid, Cell and Gene Therapies; Issues regarding the 340B Drug Pricing Program; Issues related to the implementation of Consolidated Appropriations Act, 2024 (PL 118-42); Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); H.R. 1672 - Maintaining Investments in New Innovation Act; Issues related to Most Favored Nation policy; H.R. 3037 / S. 1500 Access to Breast Cancer Diagnosis Act of 2025.
Issues related to prescription drug pricing; Issues related to Medicare, Medicaid, Cell and Gene Therapies; Issues regarding the 340B Drug Pricing Program; Issues related to the implementation of Consolidated Appropriations Act, 2024 (PL 118-42); Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); H.R. 1672 - Maintaining Investments in New Innovation Act; Issues related to Most Favored Nation policy; H.R. 3037 / S. 1500 Access to Breast Cancer Diagnostic Act of 2025.
Ensuring Community Access to Pharmacist Services Act
Client: INDEPENDENT PHARMACY COOPERATIVE · Firm: FORBES-TATE
Issues related to Pharmacy Benefit Manager (PBM) transparency and reform and continued implementation of the Medicare Drug Price Negotiation program; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to S. 927 - Protecting Pharmacies in Medicaid Act; Issues related to H.R. 4317 - PBM Reform Act of 2025; Issues related to H.R. 3164/S. 2426 - Equitable Community Access to Pharmacist Services Act.
Ensuring Community Access to Pharmacist Services Act
Client: INDEPENDENT PHARMACY COOPERATIVE · Firm: FORBES-TATE
Issues related to Pharmacy Benefit Manager (PBM) transparency and reform and continued implementation of the Medicare Drug Price Negotiation program; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to S. 927 - Protecting Pharmacies in Medicaid Act; Issues related to H.R. 4317 - PBM Reform Act of 2025; Issues related to S. 2426 - Equitable Community Access to Pharmacist Services Act; Issues related to H.R. 3164 - Main Street Pharmacy Act.
Treat and Reduce Obesity Act of 2025
Client: ELI LILLY AND COMPANY FKA LILLY USA, LLC · Firm: FORBES-TATE
Issues regarding the Centers for Medicare and Medicaid Services National Coverage Decision (NCD) on Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease; Issues related to H.R. 4231/S. 1973 - Treat and Reduce Obesity Act of 2025; Issues related to H.R. 5316 - Drug Shortage Compounding Patient Access Act of 2025; Issues related to H.R. 6509 - SAFE Drugs Act of 2025; Issues related to S. 3794 - SAFE Drugs Act of 2026.
Treat and Reduce Obesity Act of 2025
Client: ELI LILLY AND COMPANY FKA LILLY USA, LLC · Firm: FORBES-TATE
Issues regarding the Centers for Medicare and Medicaid Services National Coverage Decision (NCD) on Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease; Issues related to H.R. 4231/S. 1973 - Treat and Reduce Obesity Act of 2025; Issues related to H.R. 5316 - Drug Shortage Compounding Patient Access Act of 2025; Issues related to H.R. 6509 - SAFE Drugs Act of 2025; Issues related to S. 3794 - SAFE Drugs Act of 2026.
Treat and Reduce Obesity Act of 2025
Client: ELI LILLY AND COMPANY FKA LILLY USA, LLC · Firm: FORBES-TATE
Issues regarding the Centers for Medicare and Medicaid Services National Coverage Decision (NCD) on Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease; Issues related to H.R. 4231/S. 1973 - Treat and Reduce Obesity Act of 2025; Issues related to H.R. 5316 - Drug Shortage Compounding Patient Access Act of 2025; Issues related to H.R. 6509 - SAFE Drugs Act of 2025; Issues related to S. 3794 - SAFE Drugs Act of 2026.
Issues related to Pharmacy Benefit Manager (PBM) transparency and reform and continued implementation of the Medicare Drug Price Negotiation program; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to S. 927 - Protecting Pharmacies in Medicaid Act; Issues related to H.R. 4317 - PBM Reform Act of 2025; Issues related to S. 2426 - Equitable Community Access to Pharmacist Services Act; Issues related to H.R. 3164 - Main Street Pharmacy Act.
Issues related to Pharmacy Benefit Manager (PBM) transparency and reform and continued implementation of the Medicare Drug Price Negotiation program; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to S. 927 - Protecting Pharmacies in Medicaid Act; Issues related to H.R. 4317 - PBM Reform Act of 2025; Issues related to H.R. 3164/S. 2426 - Equitable Community Access to Pharmacist Services Act.
Issues related to Pharmacy Benefit Manager (PBM) transparency and reform and continued implementation of the Medicare Drug Price Negotiation program; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to S. 927 - Protecting Pharmacies in Medicaid Act; Issues related to H.R. 4317 - PBM Reform Act of 2025; Issues related to S. 2426 - Equitable Community Access to Pharmacist Services Act.
One Big Beautiful Bill Act (PL 119-21); Issues related to Tax Relief for American Families and Workers; Issues related to H.R. 5099 - SAFES Act.
Issues related to the One Big Beautiful Bill Act (PL 119-21); Issues related to Tax Relief for American Families and Workers; Issues related to H.R. 5099 - SAFES Act.
Drug Shortage Compounding Patient Access Act of 2025
Client: ELI LILLY AND COMPANY FKA LILLY USA, LLC · Firm: FORBES-TATE
Issues regarding the Centers for Medicare and Medicaid Services National Coverage Decision (NCD) on Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease; Issues related to H.R. 4231/S. 1973 - Treat and Reduce Obesity Act of 2025; Issues related to H.R. 5316 - Drug Shortage Compounding Patient Access Act of 2025; Issues related to H.R. 6509 - SAFE Drugs Act of 2025; Issues related to S. 3794 - SAFE Drugs Act of 2026.
Drug Shortage Compounding Patient Access Act of 2025
Client: ELI LILLY AND COMPANY FKA LILLY USA, LLC · Firm: FORBES-TATE
Issues regarding the Centers for Medicare and Medicaid Services National Coverage Decision (NCD) on Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease; Issues related to H.R. 4231/S. 1973 - Treat and Reduce Obesity Act of 2025; Issues related to H.R. 5316 - Drug Shortage Compounding Patient Access Act of 2025; Issues related to H.R. 6509 - SAFE Drugs Act of 2025; Issues related to S. 3794 - SAFE Drugs Act of 2026.
Drug Shortage Compounding Patient Access Act of 2025
Client: ELI LILLY AND COMPANY FKA LILLY USA, LLC · Firm: FORBES-TATE
Issues regarding the Centers for Medicare and Medicaid Services National Coverage Decision (NCD) on Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease; Issues related to H.R. 4231/S. 1973 - Treat and Reduce Obesity Act of 2025; Issues related to H.R. 5316 - Drug Shortage Compounding Patient Access Act of 2025; Issues related to H.R. 6509 - SAFE Drugs Act of 2025; Issues related to S. 3794 - SAFE Drugs Act of 2026.
Drug Shortage Compounding Patient Access Act of 2025
Client: ELI LILLY AND COMPANY FKA LILLY USA, LLC · Firm: FORBES-TATE
Issues related to Insulin pricing; Issues related to the pricing of GLP-1 therapeutic products; Issues regarding the 340B Drug Pricing Program; Issues related to H.R. 5316 - Drug Shortage Compounding Patient Access Act of 2025; Issues related to H.R. 6509 - SAFE Drugs Act of 2025; Issues related to S. 3794 - SAFE Drugs Act of 2026.
Drug Shortage Compounding Patient Access Act of 2025
Client: ELI LILLY AND COMPANY FKA LILLY USA, LLC · Firm: FORBES-TATE
Issues related to Insulin pricing; Issues related to the pricing of GLP-1 therapeutic products; Issues regarding the 340B Drug Pricing Program; Issues related to H.R. 5316 - Drug Shortage Compounding Patient Access Act of 2025; Issues related to H.R. 6509 - SAFE Drugs Act of 2025; Issues related to S. 3794 - SAFE Drugs Act of 2026.
Drug Shortage Compounding Patient Access Act of 2025
Client: ELI LILLY AND COMPANY FKA LILLY USA, LLC · Firm: FORBES-TATE
Issues related to insulin pricing; Issues related to the pricing of GLP-1 therapeutic products; Issues regarding the 340B Drug Pricing Program; Issues related to H.R. 5316 - Drug Shortage Compounding Patient Access Act of 2025; Issues related to H.R. 6509 - SAFE Drugs Act of 2025; Issues related to S. 3794 - SAFE Drugs Act of 2026.
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to H.R. 5737/S. 1692 - Radiology Outpatient Ordering Transmission (ROOT) Act.
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to Consolidated Appropriations Act, 2026 (PL 119-75); Issues related to SUPPORT for Patients and Communities Reauthorization Act of 2025 (PL 119-44); Issues related to H.R. 5737/S. 1692 - Radiology Outpatient Ordering Transmission (ROOT) Act.
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to H.R. 5737/S. 1692 - Radiology Outpatient Ordering Transmission (ROOT) Act.
Doctor Knows Best Act of 2025
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to H.R. 5737/S. 1692 - Radiology Outpatient Ordering Transmission (ROOT) Act.
Doctor Knows Best Act of 2025
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to H.R. 5737/S. 1692 - Radiology Outpatient Ordering Transmission (ROOT) Act.
Doctor Knows Best Act of 2025
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to Consolidated Appropriations Act, 2026 (PL 119-75); Issues related to SUPPORT for Patients and Communities Reauthorization Act of 2025 (PL 119-44); Issues related to H.R. 5737/S. 1692 - Radiology Outpatient Ordering Transmission (ROOT) Act.
Issues related to insulin pricing; Issues related to the pricing of GLP-1 therapeutic products; Issues regarding the 340B Drug Pricing Program; Issues related to H.R. 5316 - Drug Shortage Compounding Patient Access Act of 2025; Issues related to H.R. 6509 - SAFE Drugs Act of 2025; Issues related to S. 3794 - SAFE Drugs Act of 2026.
Issues regarding the Centers for Medicare and Medicaid Services National Coverage Decision (NCD) on Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease; Issues related to H.R. 4231/S. 1973 - Treat and Reduce Obesity Act of 2025; Issues related to H.R. 5316 - Drug Shortage Compounding Patient Access Act of 2025; Issues related to H.R. 6509 - SAFE Drugs Act of 2025; Issues related to S. 3794 - SAFE Drugs Act of 2026.
Issues related to Insulin pricing; Issues related to the pricing of GLP-1 therapeutic products; Issues regarding the 340B Drug Pricing Program; Issues related to H.R. 5316 - Drug Shortage Compounding Patient Access Act of 2025; Issues related to H.R. 6509 - SAFE Drugs Act of 2025; Issues related to S. 3794 - SAFE Drugs Act of 2026.
Issues regarding the Centers for Medicare and Medicaid Services National Coverage Decision (NCD) on Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease; Issues related to H.R. 4231/S. 1973 - Treat and Reduce Obesity Act of 2025; Issues related to H.R. 5316 - Drug Shortage Compounding Patient Access Act of 2025; Issues related to H.R. 6509 - SAFE Drugs Act of 2025; Issues related to S. 3794 - SAFE Drugs Act of 2026.
Issues regarding the Centers for Medicare and Medicaid Services National Coverage Decision (NCD) on Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease; Issues related to H.R. 4231/S. 1973 - Treat and Reduce Obesity Act of 2025; Issues related to H.R. 5316 - Drug Shortage Compounding Patient Access Act of 2025; Issues related to H.R. 6509 - SAFE Drugs Act of 2025; Issues related to S. 3794 - SAFE Drugs Act of 2026.
Issues related to Insulin pricing; Issues related to the pricing of GLP-1 therapeutic products; Issues regarding the 340B Drug Pricing Program; Issues related to H.R. 5316 - Drug Shortage Compounding Patient Access Act of 2025; Issues related to H.R. 6509 - SAFE Drugs Act of 2025; Issues related to S. 3794 - SAFE Drugs Act of 2026.
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to Consolidated Appropriations Act, 2026 (PL 119-75); Issues related to SUPPORT for Patients and Communities Reauthorization Act of 2025 (PL 119-44); Issues related to H.R. 5737/S. 1692 - Radiology Outpatient Ordering Transmission (ROOT) Act.
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to H.R. 5737/S. 1692 - Radiology Outpatient Ordering Transmission (ROOT) Act.
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to the CY 2025 Medicare Physician Fee Schedule proposed rule; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to Consolidated Appropriations Act, 2026 (PL 119-75); Issues related to SUPPORT for Patients and Communities Reauthorization Act of 2025 (PL 119-44).
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to the CY 2025 Medicare Physician Fee Schedule proposed rule; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to Consolidated Appropriations Act, 2026 (PL 119-75); Issues related to SUPPORT for Patients and Communities Reauthorization Act of 2025 (PL 119-44).
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to the CY 2025 Medicare Physician Fee Schedule proposed rule; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to Consolidated Appropriations Act, 2026 (PL 119-75); Issues related to SUPPORT for Patients and Communities Reauthorization Act of 2025 (PL 119-44).
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to H.R. 5737/S. 1692 - Radiology Outpatient Ordering Transmission (ROOT) Act.
Issues related to workforce in general. Issues related to H.R. 8870 - BUILDAmerica250Act.
Issues related to workforce in general; Issues related to H.R. 8870 - BUILDAmerica250Act.
Issues related to prescription drug pricing; Issues related to Medicare, Medicaid, Cell and Gene Therapies; Issues regarding the 340B Drug Pricing Program; Issues related to the implementation of Consolidated Appropriations Act, 2024 (PL 118-42); Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); H.R. 1672 - Maintaining Investments in New Innovation Act; Issues related to Most Favored Nation policy; H.R. 3037 / S. 1500 Access to Breast Cancer Diagnostic Act of 2025.
Issues related to prescription drug pricing; Issues related to Medicare, Medicaid, Cell and Gene Therapies; Issues regarding the 340B Drug Pricing Program; Issues related to the implementation of Consolidated Appropriations Act, 2024 (PL 118-42); Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); H.R. 1672 - Maintaining Investments in New Innovation Act; Issues related to Most Favored Nation policy; H.R. 3037/S. 1500 - Access to Breast Cancer Diagnosis Act of 2025.
Issues related to prescription drug pricing; Issues related to Medicare, Medicaid, Cell and Gene Therapies; Issues regarding the 340B Drug Pricing Program; Issues related to the implementation of Consolidated Appropriations Act, 2024 (PL 118-42); Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); H.R. 1672 - Maintaining Investments in New Innovation Act; Issues related to Most Favored Nation policy; H.R. 3037 / S. 1500 Access to Breast Cancer Diagnosis Act of 2025.
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to H.R. 5737/S. 1692 - Radiology Outpatient Ordering Transmission (ROOT) Act.
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to Consolidated Appropriations Act, 2026 (PL 119-75); Issues related to SUPPORT for Patients and Communities Reauthorization Act of 2025 (PL 119-44); Issues related to H.R. 5737/S. 1692 - Radiology Outpatient Ordering Transmission (ROOT) Act.
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to the CY 2025 Medicare Physician Fee Schedule proposed rule; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to Consolidated Appropriations Act, 2026 (PL 119-75); Issues related to SUPPORT for Patients and Communities Reauthorization Act of 2025 (PL 119-44).
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to H.R. 5737/S. 1692 - Radiology Outpatient Ordering Transmission (ROOT) Act.
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to the CY 2025 Medicare Physician Fee Schedule proposed rule; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to Consolidated Appropriations Act, 2026 (PL 119-75); Issues related to SUPPORT for Patients and Communities Reauthorization Act of 2025 (PL 119-44).
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to the CY 2025 Medicare Physician Fee Schedule proposed rule; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to Consolidated Appropriations Act, 2026 (PL 119-75); Issues related to SUPPORT for Patients and Communities Reauthorization Act of 2025 (PL 119-44).
Radiology Outpatient Ordering Transmission (ROOT) Act
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to H.R. 5737/S. 1692 - Radiology Outpatient Ordering Transmission (ROOT) Act.
Radiology Outpatient Ordering Transmission (ROOT) Act
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to Consolidated Appropriations Act, 2026 (PL 119-75); Issues related to SUPPORT for Patients and Communities Reauthorization Act of 2025 (PL 119-44); Issues related to H.R. 5737/S. 1692 - Radiology Outpatient Ordering Transmission (ROOT) Act.
Radiology Outpatient Ordering Transmission (ROOT) Act
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to H.R. 5737/S. 1692 - Radiology Outpatient Ordering Transmission (ROOT) Act.
Treat and Reduce Obesity Act of 2025
Client: ELI LILLY AND COMPANY FKA LILLY USA, LLC · Firm: FORBES-TATE
Issues regarding the Centers for Medicare and Medicaid Services National Coverage Decision (NCD) on Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease; Issues related to H.R. 4231/S. 1973 - Treat and Reduce Obesity Act of 2025; Issues related to H.R. 5316 - Drug Shortage Compounding Patient Access Act of 2025; Issues related to H.R. 6509 - SAFE Drugs Act of 2025; Issues related to S. 3794 - SAFE Drugs Act of 2026.
Treat and Reduce Obesity Act of 2025
Client: ELI LILLY AND COMPANY FKA LILLY USA, LLC · Firm: FORBES-TATE
Issues regarding the Centers for Medicare and Medicaid Services National Coverage Decision (NCD) on Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease; Issues related to H.R. 4231/S. 1973 - Treat and Reduce Obesity Act of 2025; Issues related to H.R. 5316 - Drug Shortage Compounding Patient Access Act of 2025; Issues related to H.R. 6509 - SAFE Drugs Act of 2025; Issues related to S. 3794 - SAFE Drugs Act of 2026.
Treat and Reduce Obesity Act of 2025
Client: ELI LILLY AND COMPANY FKA LILLY USA, LLC · Firm: FORBES-TATE
Issues regarding the Centers for Medicare and Medicaid Services National Coverage Decision (NCD) on Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease; Issues related to H.R. 4231/S. 1973 - Treat and Reduce Obesity Act of 2025; Issues related to H.R. 5316 - Drug Shortage Compounding Patient Access Act of 2025; Issues related to H.R. 6509 - SAFE Drugs Act of 2025; Issues related to S. 3794 - SAFE Drugs Act of 2026.
Equitable Community Access to Pharmacist Services Act
Client: INDEPENDENT PHARMACY COOPERATIVE · Firm: FORBES-TATE
Issues related to Pharmacy Benefit Manager (PBM) transparency and reform and continued implementation of the Medicare Drug Price Negotiation program; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to S. 927 - Protecting Pharmacies in Medicaid Act; Issues related to H.R. 4317 - PBM Reform Act of 2025; Issues related to S. 2426 - Equitable Community Access to Pharmacist Services Act.
Equitable Community Access to Pharmacist Services Act
Client: INDEPENDENT PHARMACY COOPERATIVE · Firm: FORBES-TATE
Issues related to Pharmacy Benefit Manager (PBM) transparency and reform and continued implementation of the Medicare Drug Price Negotiation program; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to S. 927 - Protecting Pharmacies in Medicaid Act; Issues related to H.R. 4317 - PBM Reform Act of 2025; Issues related to S. 2426 - Equitable Community Access to Pharmacist Services Act; Issues related to H.R. 3164 - Main Street Pharmacy Act.
Equitable Community Access to Pharmacist Services Act
Client: INDEPENDENT PHARMACY COOPERATIVE · Firm: FORBES-TATE
Issues related to Pharmacy Benefit Manager (PBM) transparency and reform and continued implementation of the Medicare Drug Price Negotiation program; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to S. 927 - Protecting Pharmacies in Medicaid Act; Issues related to H.R. 4317 - PBM Reform Act of 2025; Issues related to H.R. 3164/S. 2426 - Equitable Community Access to Pharmacist Services Act.
Issues regarding the Centers for Medicare and Medicaid Services National Coverage Decision (NCD) on Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease; Issues related to H.R. 4231/S. 1973 - Treat and Reduce Obesity Act of 2025; Issues related to H.R. 5316 - Drug Shortage Compounding Patient Access Act of 2025; Issues related to H.R. 6509 - SAFE Drugs Act of 2025; Issues related to S. 3794 - SAFE Drugs Act of 2026.
Issues related to Insulin pricing; Issues related to the pricing of GLP-1 therapeutic products; Issues regarding the 340B Drug Pricing Program; Issues related to H.R. 5316 - Drug Shortage Compounding Patient Access Act of 2025; Issues related to H.R. 6509 - SAFE Drugs Act of 2025; Issues related to S. 3794 - SAFE Drugs Act of 2026.
Issues related to Insulin pricing; Issues related to the pricing of GLP-1 therapeutic products; Issues regarding the 340B Drug Pricing Program; Issues related to H.R. 5316 - Drug Shortage Compounding Patient Access Act of 2025; Issues related to H.R. 6509 - SAFE Drugs Act of 2025; Issues related to S. 3794 - SAFE Drugs Act of 2026.
Issues related to insulin pricing; Issues related to the pricing of GLP-1 therapeutic products; Issues regarding the 340B Drug Pricing Program; Issues related to H.R. 5316 - Drug Shortage Compounding Patient Access Act of 2025; Issues related to H.R. 6509 - SAFE Drugs Act of 2025; Issues related to S. 3794 - SAFE Drugs Act of 2026.
Issues regarding the Centers for Medicare and Medicaid Services National Coverage Decision (NCD) on Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease; Issues related to H.R. 4231/S. 1973 - Treat and Reduce Obesity Act of 2025; Issues related to H.R. 5316 - Drug Shortage Compounding Patient Access Act of 2025; Issues related to H.R. 6509 - SAFE Drugs Act of 2025; Issues related to S. 3794 - SAFE Drugs Act of 2026.
Issues regarding the Centers for Medicare and Medicaid Services National Coverage Decision (NCD) on Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease; Issues related to H.R. 4231/S. 1973 - Treat and Reduce Obesity Act of 2025; Issues related to H.R. 5316 - Drug Shortage Compounding Patient Access Act of 2025; Issues related to H.R. 6509 - SAFE Drugs Act of 2025; Issues related to S. 3794 - SAFE Drugs Act of 2026.
Retirement Fairness for Charities and Educational Institutions Act of 2025
Client: INSURED RETIREMENT INSTITUTE · Firm: FORBES-TATE
Issues related to retirement savings; Issues related to H.R. 1013/S. 424 - The Retirement Fairness for Charities and Educational Institutions Act of 2025; Issues related to DOL Fiduciary rule.
Retirement Fairness for Charities and Educational Institutions Act of 2025
Client: INSURED RETIREMENT INSTITUTE · Firm: FORBES-TATE
Issues related to retirement savings; Issues related to H.R. 1013/S. 424 - The Retirement Fairness for Charities and Educational Institutions Act of 2025; Issues related to DOL Fiduciary rule; Issues related to the SECURE 2.0 Act (P.L. 117-328).
Retirement Fairness for Charities and Educational Institutions Act of 2025
Client: INSURED RETIREMENT INSTITUTE · Firm: FORBES-TATE
Issues related to retirement savings; Issues related to H.R. 1013/S. 424 - The Retirement Fairness for Charities and Educational Institutions Act of 2025; Issues related to DOL Fiduciary rule.
Issues related to prescription drug pricing; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to pharmacy benefit managers; H.R. 1672 - Maintaining Investments in New Innovation Act; Issues related to the 340b program; Issues related to S. 832 - EPIC Act of 2025.
Issues related to prescription drug pricing; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to pharmacy benefit managers; H.R. 1672 - Maintaining Investments in New Innovation Act; Issues related to the 340b program; Issues related to S. 832 - EPIC Act of 2025.
Issues related to prescription drug pricing; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to pharmacy benefit managers; H.R. 1672 - Maintaining Investments in New Innovation Act; Issues related to the 340b program; Issues related to S. 832 - EPIC Act of 2025.
Issues related to Pharmacy Benefit Manager (PBM) transparency and reform and continued implementation of the Medicare Drug Price Negotiation program; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to S. 927 - Protecting Pharmacies in Medicaid Act; Issues related to H.R. 4317 - PBM Reform Act of 2025; Issues related to S. 2426 - Equitable Community Access to Pharmacist Services Act; Issues related to H.R. 3164 - Main Street Pharmacy Act.
Bipartisan Health Care Act
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to H.R. 5737/S. 1692 - Radiology Outpatient Ordering Transmission (ROOT) Act.
Issues related to Pharmacy Benefit Manager (PBM) transparency and reform and continued implementation of the Medicare Drug Price Negotiation program; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to S. 927 - Protecting Pharmacies in Medicaid Act; Issues related to H.R. 4317 - PBM Reform Act of 2025; Issues related to H.R. 3164/S. 2426 - Equitable Community Access to Pharmacist Services Act.
Bipartisan Health Care Act
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to H.R. 5737/S. 1692 - Radiology Outpatient Ordering Transmission (ROOT) Act.
Issues related to Pharmacy Benefit Manager (PBM) transparency and reform and continued implementation of the Medicare Drug Price Negotiation program; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to S. 927 - Protecting Pharmacies in Medicaid Act; Issues related to H.R. 4317 - PBM Reform Act of 2025; Issues related to S. 2426 - Equitable Community Access to Pharmacist Services Act.
Protecting Pharmacies in Medicaid Act
Client: INDEPENDENT PHARMACY COOPERATIVE · Firm: FORBES-TATE
Issues related to Pharmacy Benefit Manager (PBM) transparency and reform and continued implementation of the Medicare Drug Price Negotiation program; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to S. 927 - Protecting Pharmacies in Medicaid Act; Issues related to H.R. 4317 - PBM Reform Act of 2025; Issues related to S. 2426 - Equitable Community Access to Pharmacist Services Act.
Protecting Pharmacies in Medicaid Act
Client: INDEPENDENT PHARMACY COOPERATIVE · Firm: FORBES-TATE
Issues related to Pharmacy Benefit Manager (PBM) transparency and reform and continued implementation of the Medicare Drug Price Negotiation program; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to S. 927 - Protecting Pharmacies in Medicaid Act; Issues related to H.R. 4317 - PBM Reform Act of 2025; Issues related to S. 2426 - Equitable Community Access to Pharmacist Services Act; Issues related to H.R. 3164 - Main Street Pharmacy Act.
Protecting Pharmacies in Medicaid Act
Client: INDEPENDENT PHARMACY COOPERATIVE · Firm: FORBES-TATE
Issues related to Pharmacy Benefit Manager (PBM) transparency and reform and continued implementation of the Medicare Drug Price Negotiation program; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to S. 927 - Protecting Pharmacies in Medicaid Act; Issues related to H.R. 4317 - PBM Reform Act of 2025; Issues related to H.R. 3164/S. 2426 - Equitable Community Access to Pharmacist Services Act.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: ELI LILLY AND COMPANY FKA LILLY USA, LLC · Firm: FORBES-TATE
Issues related to the report accompanying the FY 26 Senate Labor-HHS-Education Appropriations; Issues related to Rx drug pricing in H.R. 1 - the One Big Beautiful Bill Act.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: TRACTOR SUPPLY CO. · Firm: FORBES-TATE
H.R. 1 - One Big Beautiful Bill Act; Issues related to Tax Relief for American Families and Workers.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: INDEPENDENT PHARMACY COOPERATIVE · Firm: FORBES-TATE
Issues related to Pharmacy Benefit Manager (PBM) transparency and reform and continued implementation of the Medicare Drug Price Negotiation Program in H.R. 1 - the One Big Beautiful Bill Act.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to the Medicare Physician Fee Schedule and Authorized Use Criteria (AUC) in H.R. 1 - One Big Beautiful Bill Act.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: TRACTOR SUPPLY CO. · Firm: FORBES-TATE
H.R. 1 - One Big Beautiful Bill Act; Issues related to Tax Relief for American Families and Workers.
Retirement Fairness for Charities and Educational Institutions Act of 2025
Client: INSURED RETIREMENT INSTITUTE · Firm: FORBES-TATE
Issues related to retirement savings; Issues related to H.R. 1013/S. 424 - The Retirement Fairness for Charities and Educational Institutions Act of 2025; Issues related to DOL Fiduciary rule.
Retirement Fairness for Charities and Educational Institutions Act of 2025
Client: INSURED RETIREMENT INSTITUTE · Firm: FORBES-TATE
Issues related to retirement savings; Issues related to H.R. 1013/S. 424 - The Retirement Fairness for Charities and Educational Institutions Act of 2025; Issues related to DOL Fiduciary rule.
Retirement Fairness for Charities and Educational Institutions Act of 2025
Client: INSURED RETIREMENT INSTITUTE · Firm: FORBES-TATE
Issues related to retirement savings; Issues related to H.R. 1013 - The Retirement Fairness for Charities and Educational Institutions Act of 2025; Issues related to DOL Fiduciary rule.
Issues related to prescription drug pricing; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to pharmacy benefit managers; H.R. 1672 - Maintaining Investments in New Innovation Act; Issues related to the 340b program.
Issues related to prescription drug pricing; Issues related to Medicare, Medicaid, Cell and Gene Therapies; Issues regarding the 340B Drug Pricing Program; Issues related to the implementation of Consolidated Appropriations Act, 2024 (PL 118-42); Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); H.R. 1672 - Maintaining Investments in New Innovation Act.
Issues related to prescription drug pricing; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to pharmacy benefit managers; H.R. 1672 - Maintaining Investments in New Innovation Act; Issues related to the 340b program; Issues related to S. 832 - EPIC Act of 2025.
Issues related to prescription drug pricing; Issues related to Medicare, Medicaid, Cell and Gene Therapies; Issues regarding the 340B Drug Pricing Program; Issues related to the implementation of Consolidated Appropriations Act, 2024 (PL 118-42); Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); H.R. 1672 - Maintaining Investments in New Innovation Act.
2026 · third_quarter · Q3
Issues related to hemp & cannabis policy.
Issues related to hemp & cannabis policy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VIR BIOTECHNOLOGY, INC. via FORBES-TATE
2026 · third_quarter · Q3
Issues related to biopharmaceutical research, development, and manufacturing for infectious disease products.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
VEHO TECH, INC. via FORBES-TATE
2026 · third_quarter · Q3
Issues related to e-commerce and shipping.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · third_quarter · Q3
Issues related to legislation governing regulation of prediction markets.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
JOHNSON & JOHNSON via FORBES-TATE
2026 · third_quarter · Q3
Issues related to the 340B Drug Pricing Program.
Issues related to the 340B Drug Pricing Program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
I AM ALS via FORBES-TATE
2026 · third_quarter · Q3
Issues related to Veterans with ALS, access to ALS care, and appropriations funding.
Issues related to Veterans with ALS, access to ALS care, and appropriations funding.
Issues related to Veterans with ALS, access to ALS care, and appropriations funding.
UBER TECHNOLOGIES, INC. via FORBES-TATE
2026 · third_quarter · Q3
Issues related to transportation and food delivery; Issues related to transportation bill reauthorization.
Issues related to transportation and food delivery.
Issues related to transportation and food delivery.
TYSON SHARED SERVICES, INC. via FORBES-TATE
2026 · third_quarter · Q3
Issues related to livestock and food pricing.
Issues related to workplace standards; Issues related to livestock and food pricing.
Issues related to workplace standards; Issues related to livestock and food pricing.
THE CURE COALITION via FORBES-TATE
2026 · third_quarter · Q3
Issues related to medical innovation and drug development.
Issues related to medical innovation and drug development.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TRACTOR SUPPLY CO. via FORBES-TATE
2026 · third_quarter · Q3
Issues related to tariffs and trade.
Issues related to federal land use.
Issues related to tariffs and trade.
SUMRELL SUGG OBO CAROLINAEAST HEALTH SYSTEM via FORBES-TATE
2026 · third_quarter · Q3
Issues related to hospital reimbursement.
Issues related to hospital reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHRMA via FORBES-TATE
2026 · third_quarter · Q3
Issues pertaining to prescription drug pricing; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to pharmacy benefit managers; Issues related to the Medicaid Drug Rebate Program.
Issues related to data exclusivity under the United States Mexico Canada Agreement (USMCA); Issues regarding the World Trade Organization's TRIPS Waiver on COVID Vaccines; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the Medicaid Drug Rebate Program.
Issues pertaining to prescription drug pricing; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the Medicaid Drug Rebate Program.
NOVARTIS, INC. via FORBES-TATE
2026 · third_quarter · Q3
Issues related to prescription drug pricing; Issues related to pharmaceutical intellectual property; Issues related to international trade; Issues related to the 340b program.
Issues related to prescription drug pricing; Issues related to Medicare, Medicaid, Cell and Gene Therapies; Issues regarding the 340B Drug Pricing Program; Issues related to the implementation of Consolidated Appropriations Act, 2024 (PL 118-42); Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); H.R. 1672 - Maintaining Investments in New Innovation Act; Issues related to Most Favored Nation policy; H.R. 3037/S. 1500 - Access to Breast Cancer Diagnosis Act of 2025.
REGISTER AMERICA via FORBES-TATE
2026 · third_quarter · Q3
Issues related to voter registration programs.
Filing targets: HOUSE OF REPRESENTATIVES
OFFICE OF THE COMMISSIONER OF BASEBALL D/B/A MAJOR LEAGUE BASEBALL via FORBES-TATE
2026 · third_quarter · Q3
Issues related to media rights.
Issues related to antitrust.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ELI LILLY AND COMPANY FKA LILLY USA, LLC via FORBES-TATE
2026 · third_quarter · Q3
Issues regarding the Centers for Medicare and Medicaid Services National Coverage Decision (NCD) on Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease; Issues related to H.R. 4231/S. 1973 - Treat and Reduce Obesity Act of 2025; Issues related to H.R. 5316 - Drug Shortage Compounding Patient Access Act of 2025; Issues related to H.R. 6509 - SAFE Drugs Act of 2025; Issues related to S. 3794 - SAFE Drugs Act of 2026.
Issues related to the report accompanying the FY 26 Senate Labor-HHS-Education Appropriations; Issues related to Rx drug pricing in the One Big Beautiful Bill Act (PL 119-21).
GENENTECH via FORBES-TATE
2026 · third_quarter · Q3
Issues related to international tax and R&D amortization credit in the Tax Cuts and Jobs Act (PL 115-97); Issues related to tax; Issues related to the implementation of the Tax Cuts and Jobs Act (PL 115-97); Issues related to the Medicaid Drug Rebate Program.
Issues related to funding of the strategic national stockpile; Issues related to the Tax Cuts and Jobs Act (PL 115-97); Issues related to the Medicaid Drug Rebate Program.
Issues regarding the Center for Medicare and Medicaid Innovation; Issues related to the implementation of the Tax Cuts and Jobs Act (PL 115-97); Issues related to the Medicaid Drug Rebate Program.
AMERICAN HONDA MOTOR CO., INC. via FORBES-TATE
2026 · third_quarter · Q3
Issues related to workforce in general; Issues related to H.R. 8870 - BUILDAmerica250Act.
Filing targets: Consumer Product Safety Commission (CPSC), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
ALTRIA CLIENT SERVICES LLC via FORBES-TATE
2026 · third_quarter · Q3
Issues related to tobacco tax; Issues related to excise tax on tobacco in the Inflation Reduction Act of 2022 (PL 117-169); Issues related to drawback provision in H.R.1 - the One Big Beautiful Bill Act (PL 119-21).
Issues related to the International Trade Commission.
Issues related to flavors in Tobacco products; Conversations concerning federal appropriations policy related to FDA clarity on CBD; Issues related to unregulated vape products.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR CANNABIS POLICY, EDUCATION, AND REGULATION via FORBES-TATE
2026 · third_quarter · Q3
Issues pertaining to government-wide federal regulation of cannabis.
Issues related to government-wide federal regulation of cannabis; Issues related to the implementation of the Commerce, Justice, Science, and Related Agencies Appropriations Act, 2024 (PL 118-42); Issues related to transportation infrastructure, highway safety, and federal transit funding.
Issues pertaining to government-wide federal regulation of cannabis.
CANN INC. via FORBES-TATE
2026 · third_quarter · Q3
Issues related to a carve out for THC beverages from the federal ban on intoxicating hemp products.
Issues related to a carve out for THC beverages from the federal ban on intoxicating hemp products.
Issues related to a carve out for THC beverages from the federal ban on intoxicating hemp products.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CALIFORNIA LIFE SCIENCES ASSOCIATION via FORBES-TATE
2026 · third_quarter · Q3
Issues related to the life sciences industry; Issues related to drug pricing; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169).
Issues related to the life sciences industry; Issues related to drug pricing; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169).
Issues related to the life sciences industry; Issues related to drug pricing; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to Pharmacy Benefit Managers.
ASSOCIATION OF AMERICAN MEDICAL COLLEGES via FORBES-TATE
2026 · third_quarter · Q3
Issues related to medical education and research; Issues related to funding for NIH and biomedical research; Issues related to diversity in medical education; Issues related to financial assistance for medical education.
Issues related to medical education and research; Issues related to funding for NIH and biomedical research; Issues related to diversity in medical education.
Issues related to teaching hospitals; Issues related to hospital reimbursement.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMGEN USA, INC. via FORBES-TATE
2026 · third_quarter · Q3
Issues related to Biosimilars; Issues related to drug pricing; Issues related to the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the Medicaid Drug Rebate Program; Issues related to the 340b program.
Issues related to prescription drug pricing; Issues related to drug pricing; Issues related to the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the Medicaid Drug Rebate Program; Issues related to the 340b program.
Issues related to the implementation of international tax and tax reform in the Tax Cuts and Jobs Act (PL 115-97); Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the Medicaid Drug Rebate Program; Issues related to the 340b program.
AMERICAN INDEPENDENT MEDICAL PRACTICE ASSOCIATION via FORBES-TATE
2026 · third_quarter · Q3
Issues related to healthcare; Issues related to provider reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION via FORBES-TATE
2026 · third_quarter · Q3
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to H.R. 5737/S. 1692 - Radiology Outpatient Ordering Transmission (ROOT) Act.
Issues related to surprise billing; Issues related to prior authorization in Medicare and Medicaid.
ALEXION PHARMACEUTICALS, INC. via FORBES-TATE
2026 · third_quarter · Q3
Issues related to healthcare, including drug pricing and Medicare Part D; Issues related to orphan drug tax credit; Issues related to rare disease; Issues related to the Inflation Reduction Act of 2022 (PL 117-169); Issues related to orphan drugs under the Drug Price Negotiation Program.
Issues related to healthcare, including drug pricing and Medicare Part D; Issues related to the Inflation Reduction Act of 2022 (PL 117-169).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MERCK KGAA DARMSTADT GERMANY via FORBES-TATE
2026 · third_quarter · Q3
Issues related to chemical manufacturing.
Issues related to life sciences, laboratory and chemical manufacturing.
Issues related to domestic and international trade and tariff policies.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
IRON MOUNTAIN INFORMATION MANAGEMENT, LLC via FORBES-TATE
2026 · third_quarter · Q3
Issues related to privacy and data security legislation related to consumer data breach notification; Issues related to data centers.
Issues related to federal records management; Issues related to House Transportation and Infrastructure Committee Resolution regarding Prospectus PPA-FBC-BO17; Issues related to federal record storage; Issues related to federal records management for the VA; Issues related to data centers.
Issues related to Department of Defense operations, including records management; Issues related to the implementation of the American Rescue Plan Act of 2021 (PL 117-2); Issues related to data centers.
INSURED RETIREMENT INSTITUTE via FORBES-TATE
2026 · third_quarter · Q3
Issues related to retirement savings; Issues related to H.R. 1013/S. 424 - The Retirement Fairness for Charities and Educational Institutions Act of 2025; Issues related to DOL Fiduciary rule; Issues related to the SECURE 2.0 Act (P.L. 117-328).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INDEPENDENT PHARMACY COOPERATIVE via FORBES-TATE
2026 · third_quarter · Q3
Issues related to Pharmacy Benefit Manager (PBM) transparency and reform and continued implementation of the Medicare Drug Price Negotiation program; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to S. 927 - Protecting Pharmacies in Medicaid Act; Issues related to H.R. 4317 - PBM Reform Act of 2025; Issues related to H.R. 3164/S. 2426 - Equitable Community Access to Pharmacist Services Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · third_quarter · Q3
Healthcare issues regarding oncology and early multi-cancer detection, including diagnostics and screening; Medicare issues regarding oncology and early multi-cancer detection, including diagnostics and screening.
Healthcare issues regarding oncology and early multi-cancer detection, including diagnostics and screening; Medicare issues regarding oncology and early multi-cancer detection, including diagnostics and screening.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GLOBAL MEDICAL RESPONSE via FORBES-TATE
2026 · third_quarter · Q3
Issues related to Medicare and Medicaid reimbursement, workforce issues and implementation of the Consolidated Appropriations Act of 2021 (PL 116-260); Issues related to Medicaid plan amendments.
Issues related to Medicare and Medicaid reimbursement, workforce issues and implementation of the Consolidated Appropriations Act of 2021 (PL 116-260).
Issues related to FEMA emergency transport response.
Filing targets: Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, SENATE
DIGESTIVE HEALTH PHYSICIANS ASSOCIATION via FORBES-TATE
2026 · third_quarter · Q3
Issues related to healthcare data; Issues related to provider reimbursement.
Issues related to Medicare Advantage; Issues related to physician payments.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ANYWHERE REAL ESTATE INC. via FORBES-TATE
2026 · second_quarter · 2@
Issues related to the business of real estate, home ownership, antitrust, privacy, cyber.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UBER TECHNOLOGIES, INC. via FORBES-TATE
2026 · second_quarter · 2A
Issues related to transportation and food delivery.
Issues related to transportation and food delivery; Issues related to transportation bill reauthorization.
Issues related to transportation and food delivery.
SOUTHEASTERN LUMBER MANUFACTURERS ASSOCIATION via FORBES-TATE
2026 · third_quarter · 3T
Issues related to Farm Bill Reauthorization; Issues related to the reintroduction of the Timber Innovation for Building Rural Communities Act (TIBRC) / 2026 Agriculture Appropriations; Issues related to Defense and Interior Appropriations; Issues related to extension of provisions in the Tax Cuts and Jobs Act (TCJA) (P.L. 115-97).
Issues related to Farm Bill Reauthorization; Issues related to the reintroduction of the Timber Innovation for Building Rural Communities Act (TIBRC) / 2026 Agriculture Appropriations; Issues related to Defense and Interior Appropriations; Issues related to extension of provisions in the Tax Cuts and Jobs Act (TCJA) (P.L. 115-97).
BREWERS ASSOCIATION via FORBES-TATE
2026 · third_quarter · RR
Issues related to beer excise tax.
Issues related to beer excise tax.
2026 · third_quarter · 3T
Issues related to shipping logistics and small business.
Issues related to shipping logistics and small business.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
JOHNSON & JOHNSON via FORBES-TATE
2026 · third_quarter · RR
Issues related to the 340B Drug Pricing Program.
Issues related to the 340B Drug Pricing Program.
2026 · second_quarter · Q2
Issues related to shipping logistics and small business.
Issues related to shipping logistics and small business.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION OF AMERICAN MEDICAL COLLEGES via FORBES-TATE
2026 · second_quarter · Q2
Issues related to medical education and research; Issues related to funding for NIH and biomedical research; Issues related to diversity in medical education; Issues related to financial assistance for medical education.
Issues related to teaching hospitals; Issues related to hospital reimbursement.
Issues related to medical education and research; Issues related to funding for NIH and biomedical research; Issues related to diversity in medical education.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
REGISTER AMERICA via FORBES-TATE
2026 · second_quarter · Q2
Issues related to voter registration programs.
Filing targets: HOUSE OF REPRESENTATIVES
CALIFORNIA LIFE SCIENCES ASSOCIATION via FORBES-TATE
2026 · second_quarter · Q2
Issues related to the life sciences industry; Issues related to drug pricing; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169).
Issues related to the life sciences industry; Issues related to drug pricing; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to Pharmacy Benefit Managers.
Issues related to the life sciences industry; Issues related to drug pricing; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to Pharmacy Benefit Managers.
INSURED RETIREMENT INSTITUTE via FORBES-TATE
2026 · second_quarter · Q2
Issues related to retirement savings; Issues related to H.R. 1013/S. 424 - The Retirement Fairness for Charities and Educational Institutions Act of 2025; Issues related to DOL Fiduciary rule.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CANN INC. via FORBES-TATE
2026 · second_quarter · Q2
Issues related to a carve out for THC beverages from the federal ban on intoxicating hemp products.
Issues related to a carve out for THC beverages from the federal ban on intoxicating hemp products.
Issues related to a carve out for THC beverages from the federal ban on intoxicating hemp products.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TYSON SHARED SERVICES, INC. via FORBES-TATE
2026 · second_quarter · Q2
Issues related to workplace standards; Issues related to livestock and food pricing.
Issues related to workplace standards; Issues related to livestock and food pricing.
Issues related to Xylazine usage.
AMERICAN INDEPENDENT MEDICAL PRACTICE ASSOCIATION via FORBES-TATE
2026 · second_quarter · Q2
Issues related to healthcare; Issues related to provider reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR CANNABIS POLICY, EDUCATION, AND REGULATION via FORBES-TATE
2026 · second_quarter · Q2
Issues pertaining to government-wide federal regulation of cannabis.
Issues pertaining to government-wide federal regulation of cannabis.
Issues related to government-wide federal regulation of cannabis; Issues related to the implementation of the Commerce, Justice, Science, and Related Agencies Appropriations Act, 2024 (PL 118-42); Issues related to transportation infrastructure, highway safety, and federal transit funding.
AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION via FORBES-TATE
2026 · second_quarter · Q2
Issues related to the CY 2025 Medicare Physician Fee Schedule proposed rule; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to Consolidated Appropriations Act, 2026 (PL 119-75); Issues related to SUPPORT for Patients and Communities Reauthorization Act of 2025 (PL 119-44).
Issues related to surprise billing; Issues related to prior authorization in Medicare and Medicaid.
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to H.R. 5737/S. 1692 - Radiology Outpatient Ordering Transmission (ROOT) Act.
THE CURE COALITION via FORBES-TATE
2026 · second_quarter · Q2
Issues related to medical innovation and drug development.
Issues related to medical innovation and drug development.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UBER TECHNOLOGIES, INC. via FORBES-TATE
2026 · second_quarter · Q2
Issues related to transportation and food delivery.
Issues related to transportation and food delivery.
Issues related to transportation and food delivery.
INDEPENDENT PHARMACY COOPERATIVE via FORBES-TATE
2026 · second_quarter · Q2
Issues related to Pharmacy Benefit Manager (PBM) transparency and reform and continued implementation of the Medicare Drug Price Negotiation program; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to S. 927 - Protecting Pharmacies in Medicaid Act; Issues related to H.R. 4317 - PBM Reform Act of 2025; Issues related to S. 2426 - Equitable Community Access to Pharmacist Services Act; Issues related to H.R. 3164 - Main Street Pharmacy Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALEXION PHARMACEUTICALS, INC. via FORBES-TATE
2026 · second_quarter · Q2
Issues related to healthcare, including drug pricing and Medicare Part D; Issues related to the Inflation Reduction Act of 2022 (PL 117-169).
Issues related to healthcare, including drug pricing and Medicare Part D; Issues related to orphan drug tax credit; Issues related to rare disease; Issues related to the Inflation Reduction Act of 2022 (PL 117-169); Issues related to orphan drugs under the Drug Price Negotiation Program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VIR BIOTECHNOLOGY, INC. via FORBES-TATE
2026 · second_quarter · Q2
Issues related to biopharmaceutical research, development, and manufacturing for infectious disease products.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2026 · second_quarter · Q2
Healthcare issues regarding oncology and early multi-cancer detection, including diagnostics and screening; Medicare issues regarding oncology and early multi-cancer detection, including diagnostics and screening.
Healthcare issues regarding oncology and early multi-cancer detection, including diagnostics and screening; Medicare issues regarding oncology and early multi-cancer detection, including diagnostics and screening.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VISION MANAGEMENT SERVICES GTI via FORBES-TATE
2026 · second_quarter · Q2
Issues related to hemp & cannabis policy.
Issues related to hemp & cannabis policy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SUMRELL SUGG OBO CAROLINAEAST HEALTH SYSTEM via FORBES-TATE
2026 · second_quarter · Q2
Issues related to hospital reimbursement.
Issues related to hospital reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SOUTHEASTERN LUMBER MANUFACTURERS ASSOCIATION via FORBES-TATE
2026 · second_quarter · Q2
Issues related to Farm Bill Reauthorization; Issues related to the reintroduction of the Timber Innovation for Building Rural Communities Act (TIBRC) / 2026 Agriculture Appropriations; Issues related to Defense and Interior Appropriations; Issues related to extension of provisions in the Tax Cuts and Jobs Act (TCJA) (P.L. 115-97).
Issues related to Farm Bill Reauthorization; Issues related to the reintroduction of the Timber Innovation for Building Rural Communities Act (TIBRC) / 2026 Agriculture Appropriations; Issues related to Defense and Interior Appropriations; Issues related to extension of provisions in the Tax Cuts and Jobs Act (TCJA) (P.L. 115-97).
GLOBAL MEDICAL RESPONSE via FORBES-TATE
2026 · second_quarter · Q2
Issues related to Medicare and Medicaid reimbursement, workforce issues and implementation of the Consolidated Appropriations Act of 2021 (PL 116-260); Issues related to Medicaid plan amendments.
Issues related to Medicare and Medicaid reimbursement, workforce issues and implementation of the Consolidated Appropriations Act of 2021 (PL 116-260).
Issues related to FEMA emergency transport response.
Filing targets: Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, SENATE
AGLOGIC via FORBES-TATE
2026 · second_quarter · Q2
Issues related to the importance of science-based decisions with respect to crop protection tools in U.S. agriculture.
Issues related to the importance of science-based decisions with respect to crop protection tools in U.S. agriculture.
Filing targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR), White House Office
EDWARD D. JONES & CO., L.P. via FORBES-TATE
2026 · second_quarter · Q2
Issues related to retirement security and savings matters; Issues related to small business retirement and retirement savings; Issues related to retirement savings for military spouses; SIMPLE IRAs; Issues related to financial transaction, capital gains, and dividend income taxes; Issues related to senior investor protection matters; Issues related to SEC and DOL standard of care rulemaking; Issues related to partnership tax and IRS Code Section 199A.
Issues related to bank chartering.
Issues related to retirement security and savings matters; Issues related to small business retirement and retirement savings; Issues related to retirement savings for military spouses; SIMPLE IRAs; Issues related to financial transaction, capital gains, and dividend income taxes; Issues related to senior investor protection matters; Issues related to SEC and DOL standard of care rulemaking; Issues related to partnership tax and IRS Code Section 199A; Issues related to banking services.
DIGESTIVE HEALTH PHYSICIANS ASSOCIATION via FORBES-TATE
2026 · second_quarter · Q2
Issues related to healthcare data; Issues related to provider reimbursement.
Issues related to Medicare Advantage; Issues related to physician payments.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MERCK KGAA DARMSTADT GERMANY via FORBES-TATE
2026 · second_quarter · Q2
Issues related to chemical manufacturing.
Issues related to domestic and international trade and tariff policies.
Issues related to life sciences, laboratory and chemical manufacturing.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
TRACTOR SUPPLY CO. via FORBES-TATE
2026 · second_quarter · Q2
One Big Beautiful Bill Act (PL 119-21); Issues related to Tax Relief for American Families and Workers; Issues related to H.R. 5099 - SAFES Act.
Issues related to federal land use.
Issues related to tariffs and trade.
PHRMA via FORBES-TATE
2026 · second_quarter · Q2
Issues pertaining to prescription drug pricing; Medicare Part D; Importation of drugs; Issues related to 340b; Issues related to Drug Price Competition and Patent Term Restoration Act (PL 98-417); Issues related to Section 340B of the Public Health Service Act; Issues related to Consolidated Appropriations Act, 2022 (PL 117-103); Issues related to prescription drug user fee agreement; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the Medicaid Drug Rebate Program; Issues related to pharmacy benefit managers.
Issues pertaining to prescription drug pricing; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to pharmacy benefit managers; Issues related to the Medicaid Drug Rebate Program.
NOVARTIS, INC. via FORBES-TATE
2026 · second_quarter · Q2
Issues related to prescription drug pricing; Issues related to Medicare, Medicaid, Cell and Gene Therapies; Issues regarding the 340B Drug Pricing Program; Issues related to the implementation of Consolidated Appropriations Act, 2024 (PL 118-42); Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); H.R. 1672 - Maintaining Investments in New Innovation Act; Issues related to Most Favored Nation policy; H.R. 3037 / S. 1500 Access to Breast Cancer Diagnosis Act of 2025.
Issues related to implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the 340b program.
IRON MOUNTAIN INFORMATION MANAGEMENT, LLC via FORBES-TATE
2026 · second_quarter · Q2
Issues related to Department of Defense operations, including records management; Issues related to the implementation of the American Rescue Plan Act of 2021 (PL 117-2).
Issues related to privacy and data security legislation related to consumer data breach notification.
Issues related to consolidation of federal data centers under the Federal Information Technology Acquisition and Reform Act (PL 113-291); Issues related to federal records management for the VA.
OFFICE OF THE COMMISSIONER OF BASEBALL D/B/A MAJOR LEAGUE BASEBALL via FORBES-TATE
2026 · second_quarter · Q2
Issues related to media rights.
Issues related to antitrust.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ELI LILLY AND COMPANY FKA LILLY USA, LLC via FORBES-TATE
2026 · second_quarter · Q2
Issues related to Insulin pricing; Issues related to the pricing of GLP-1 therapeutic products; Issues regarding the 340B Drug Pricing Program; Issues related to H.R. 5316 - Drug Shortage Compounding Patient Access Act of 2025; Issues related to H.R. 6509 - SAFE Drugs Act of 2025; Issues related to S. 3794 - SAFE Drugs Act of 2026.
Issues regarding the Centers for Medicare and Medicaid Services National Coverage Decision (NCD) on Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease; Issues related to H.R. 4231/S. 1973 - Treat and Reduce Obesity Act of 2025; Issues related to H.R. 5316 - Drug Shortage Compounding Patient Access Act of 2025; Issues related to H.R. 6509 - SAFE Drugs Act of 2025; Issues related to S. 3794 - SAFE Drugs Act of 2026.
GENENTECH via FORBES-TATE
2026 · second_quarter · Q2
Issues related to Medicare and Medicaid coverage and reimbursement; Issues pertaining to 340B; Issues related to drug importation; Issues related to prescription drug pricing; Issues related to the International Pricing Index for Medicare Part D; Issues related to prescription drug user fee agreement; Issues related to the implementation of the Tax Cuts and Jobs Act (PL 115-97); Issues related to pharmacy benefit managers; Issues related to the Medicaid Drug Rebate Program.
Issues related to the 340B Drug Pricing Program.
Intellectual property and process patent related issues.
AMERICAN HONDA MOTOR CO., INC. via FORBES-TATE
2026 · second_quarter · Q2
Issues related to workforce in general. Issues related to H.R. 8870 - BUILDAmerica250Act.
Filing targets: Consumer Product Safety Commission (CPSC), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
ALTRIA CLIENT SERVICES LLC via FORBES-TATE
2026 · second_quarter · Q2
Issues related to the International Trade Commission.
Issues related to flavors in Tobacco products; Conversations concerning federal appropriations policy related to FDA clarity on CBD; Issues related to unregulated vape products.
Issues related to tobacco tax; Issues related to excise tax on tobacco in the Inflation Reduction Act of 2022 (PL 117-169); Issues related to drawback provision in H.R.1 - the One Big Beautiful Bill Act (PL 119-21).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
I AM ALS via FORBES-TATE
2026 · third_quarter · RR
Issues related to Veterans with ALS, access to ALS care, and appropriations funding.
Issues related to Veterans with ALS, access to ALS care, and appropriations funding.
Issues related to Veterans with ALS, access to ALS care, and appropriations funding.
2026 · third_quarter · RR
Issues related to legislation governing regulation of prediction markets.
VEHO TECH, INC. via FORBES-TATE
2026 · third_quarter · RR
Issues related to e-commerce & shipping.
ANYWHERE REAL ESTATE INC. via FORBES-TATE
2026 · second_quarter · 2T
Issues related to the business of real estate, home ownership, antitrust, privacy, cyber.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CLARITEV (FKA MULTIPLAN CORPORATION) via FORBES-TATE
2026 · second_quarter · 2T
Issues related to anti-trust.
Issues related to payment for healthcare services; Issues related to healthcare data transparency.
Issues pertaining to payment for healthcare services and healthcare data transparency.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PARADIGM OPERATIONS LP via FORBES-TATE
2026 · second_quarter · 2T
Issues related to prediction markets.
Issues related to stablecoin regulation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OFFICE OF THE COMMISSIONER OF BASEBALL D/B/A MAJOR LEAGUE BASEBALL via FORBES-TATE
2026 · first_quarter · 1A
Issues related to antitrust.
Issues related to media rights.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CANN INC. via FORBES-TATE
2026 · first_quarter · Q1
Issues related to a carve out for THC beverages from the federal ban on intoxicating hemp products.
Issues related to a carve out for THC beverages from the federal ban on intoxicating hemp products.
Issues related to a carve out for THC beverages from the federal ban on intoxicating hemp products.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INDEPENDENT PHARMACY COOPERATIVE via FORBES-TATE
2026 · first_quarter · Q1
Issues related to Pharmacy Benefit Manager (PBM) transparency and reform and continued implementation of the Medicare Drug Price Negotiation program; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to S. 927 - Protecting Pharmacies in Medicaid Act; Issues related to H.R. 4317 - PBM Reform Act of 2025; Issues related to S. 2426 - Equitable Community Access to Pharmacist Services Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VISION MANAGEMENT SERVICES GTI via FORBES-TATE
2026 · first_quarter · Q1
Issues related to hemp & cannabis policy.
Issues related to hemp & cannabis policy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VIR BIOTECHNOLOGY, INC. via FORBES-TATE
2026 · first_quarter · Q1
Issues related to biopharmaceutical research, development, and manufacturing for infectious disease products.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
UBER TECHNOLOGIES, INC. via FORBES-TATE
2026 · first_quarter · Q1
Issues related to transportation and food delivery; Issues related to transportation bill reauthorization.
Issues related to transportation and food delivery.
Issues related to transportation and food delivery.
TYSON SHARED SERVICES, INC. via FORBES-TATE
2026 · first_quarter · Q1
Issues related to Xylazine usage.
Issues related to workplace standards; Issues related to livestock and food pricing.
Issues related to workplace standards; Issues related to livestock and food pricing.
THE CURE COALITION via FORBES-TATE
2026 · first_quarter · Q1
Issues related to medical innovation and drug development.
Issues related to medical innovation and drug development.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TARSUS PHARMACEUTICALS via FORBES-TATE
2026 · first_quarter · Q1
Issues related to education and advocacy pertaining to life science products and pipeline.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SUMRELL SUGG OBO CAROLINAEAST HEALTH SYSTEM via FORBES-TATE
2026 · first_quarter · Q1
Issues related to hospital reimbursement.
Issues related to hospital reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SOUTHEASTERN LUMBER MANUFACTURERS ASSOCIATION via FORBES-TATE
2026 · first_quarter · Q1
Issues related to Farm Bill Reauthorization; Issues related to the reintroduction of the Timber Innovation for Building Rural Communities Act (TIBRC) / 2026 Agriculture Appropriations; Issues related to Defense and Interior Appropriations; Issues related to extension of provisions in the Tax Cuts and Jobs Act (TCJA) (P.L. 115-97).
Issues related to Farm Bill Reauthorization; Issues related to the reintroduction of the Timber Innovation for Building Rural Communities Act (TIBRC) / 2026 Agriculture Appropriations; Issues related to Defense and Interior Appropriations; Issues related to extension of provisions in the Tax Cuts and Jobs Act (TCJA) (P.L. 115-97).
RED ANGUS ASSOCIATION OF AMERICA via FORBES-TATE
2026 · first_quarter · Q1
General agriculture matters to advance Red Angus.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REGISTER AMERICA via FORBES-TATE
2026 · first_quarter · Q1
Issues related to voter registration programs.
Filing targets: HOUSE OF REPRESENTATIVES
MERCK KGAA DARMSTADT GERMANY via FORBES-TATE
2026 · first_quarter · Q1
Issues related to domestic and international trade and tariff policies.
Issues related to life sciences, laboratory and chemical manufacturing.
Issues related to chemical manufacturing.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
PARADIGM OPERATIONS LP via FORBES-TATE
2026 · first_quarter · Q1
Issues related to stablecoin regulation.
Issues related to prediction markets.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
IRON MOUNTAIN INFORMATION MANAGEMENT, LLC via FORBES-TATE
2026 · first_quarter · Q1
Issues related to consolidation of federal data centers under the Federal Information Technology Acquisition and Reform Act (PL 113-291); Issues related to federal records management for the VA.
Issues related to privacy and data security legislation related to consumer data breach notification.
Issues related to tax treatment of REITS (Real Estate Investment Trust).
INSURED RETIREMENT INSTITUTE via FORBES-TATE
2026 · first_quarter · Q1
Issues related to retirement savings; Issues related to H.R. 1013/S. 424 - The Retirement Fairness for Charities and Educational Institutions Act of 2025; Issues related to DOL Fiduciary rule.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HALOZYME THERAPEUTICS, INC. via FORBES-TATE
2026 · first_quarter · Q1
Issues related to biopharmaceutical research, development, and manufacturing.
Issues related to coverage and reimbursement.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2026 · first_quarter · Q1
Healthcare issues regarding oncology and early multi-cancer detection, including diagnostics and screening; Medicare issues regarding oncology and early multi-cancer detection, including diagnostics and screening.
Healthcare issues regarding oncology and early multi-cancer detection, including diagnostics and screening; Medicare issues regarding oncology and early multi-cancer detection, including diagnostics and screening.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GLOBAL MEDICAL RESPONSE via FORBES-TATE
2026 · first_quarter · Q1
Issues related to Medicare and Medicaid reimbursement, workforce issues and implementation of the Consolidated Appropriations Act of 2021 (PL 116-260); Issues related to Medicaid plan amendments.
Issues related to Medicare and Medicaid reimbursement, workforce issues and implementation of the Consolidated Appropriations Act of 2021 (PL 116-260).
Issues related to FEMA emergency transport response.
Filing targets: Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, SENATE
Issues related to Veterans with ALS, access to ALS care, and appropriations funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to transportation and food delivery.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to workplace standards; Issues related to livestock and food pricing; Issues related to labor union work condition negotiation.
Issues related to Xylazine usage.
Issues related to workplace standards; Issues related to livestock and food pricing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to the One Big Beautiful Bill Act (PL 119-21); Issues related to Tax Relief for American Families and Workers; Issues related to H.R. 5099 - SAFES Act.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)
Issues related to Direct to Consumer (DTC) Advertising; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the Medicaid Drug Rebate Program.
Issues pertaining to prescription drug pricing; Medicare Part D; Importation of drugs; Issues related to 340b; Issues related to Drug Price Competition and Patent Term Restoration Act (PL 98-417); Issues related to Section 340B of the Public Health Service Act; Issues related to Consolidated Appropriations Act, 2022 (PL 117-103); Issues related to prescription drug user fee agreement; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the Medicaid Drug Rebate Program; Issues related to pharmacy benefit managers.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to prescription drug pricing and Intellectual Property (IP); Issues regarding the World Trade Organization's TRIPS Waiver on COVID Vaccines; Issues related to the 340b program.
Issues related to prescription drug pricing; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the 340b program.
Issues related to implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the 340b program.
Issues related to prescription drug pricing; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to pharmacy benefit managers; H.R. 1672 - Maintaining Investments in New Innovation Act; Issues related to the 340b program; Issues related to S. 832 - EPIC Act of 2025.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to insulin pricing; Issues related to the pricing of GLP-1 therapeutic products; Issues regarding the 340B Drug Pricing Program; Issues related to H.R. 5316 - Drug Shortage Compounding Patient Access Act of 2025; Issues related to H.R. 6509 - SAFE Drugs Act of 2025; Issues related to S. 3794 - SAFE Drugs Act of 2026.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to intellectual property and process patent.
Issues related to Medicare and Medicaid coverage and reimbursement; Issues related to 340B; Issues related to drug importation; Issues related to prescription drug pricing; Issues related to the International Pricing Index for Medicare Part D; Issues related to prescription drug user fee agreement; Issues related to the implementation of the Tax Cuts and Jobs Act (PL 115-97); Issues related to pharmacy benefit managers; Issues related to the Medicaid Drug Rebate Program.
Issues related to the 340B Drug Pricing Program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues pertaining to government-wide federal regulation of cannabis.
Issues pertaining to government-wide federal regulation of cannabis.
Issues pertaining to government-wide federal regulation of cannabis.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to the life sciences industry; Issues related to drug pricing; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to Pharmacy Benefit Managers.
Issues related to the life sciences industry; Issues related to drug pricing; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169).
Issues related to the life sciences industry; Issues related to drug pricing; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to Pharmacy Benefit Managers; Issues related to transitional coverage of emerging technologies.
Issues related to the life sciences industry; Issues related to drug pricing; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the Medicaid Drug Rebate Program; Issues related to the 340b program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to the CY 2025 Medicare Physician Fee Schedule proposed rule; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to Consolidated Appropriations Act, 2026 (PL 119-75); Issues related to SUPPORT for Patients and Communities Reauthorization Act of 2025 (PL 119-44).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to consolidation of federal data centers under the Federal Information Technology Acquisition and Reform Act (PL 113-291); Issues related to federal records management for the VA; Issues related to data centers.
Issues related to tax treatment of REITS (Real Estate Investment Trust); Issues related to data centers.
Issues related to federal records management; Issues related to federal background checks; Issues related to data centers.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to transportation and food delivery.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to Farm Bill Reauthorization; Issues related to the reintroduction of the Timber Innovation for Building Rural Communities Act (TIBRC) / 2026 Agriculture Appropriations; Issues related to Defense and Interior Appropriations; Issues related to extension of provisions in the Tax Cuts and Jobs Act (TCJA) (P.L. 115-97).
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR), White House Office
Issues related to the life sciences industry; Issues related to drug pricing; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169).
Issues related to the life sciences industry; Issues related to drug pricing; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to Pharmacy Benefit Managers; Issues related to transitional coverage of emerging technologies.
Issues related to the life sciences industry; Issues related to drug pricing; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169).
Issues related to the life sciences industry; Issues related to drug pricing; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to livestock and food pricing.
Issues related to workplace standards; Issues related to livestock and food pricing; Issues related to labor union work condition negotiation.
Issues related to workplace standards; Issues related to livestock and food pricing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues pertaining to government-wide federal regulation of cannabis.
Issues pertaining to government-wide federal regulation of cannabis.
Issues pertaining to government-wide federal regulation of cannabis.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to transportation and food delivery; Issues related to transportation bill reauthorization.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to Farm Bill Reauthorization; Issues related to the reintroduction of the Timber Innovation for Building Rural Communities Act (TIBRC) / 2026 Agriculture Appropriations; Issues related to Defense and Interior Appropriations; Issues related to extension of provisions in the Tax Cuts and Jobs Act (TCJA) (P.L. 115-97).
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR), White House Office
Issues related to retirement security and savings matters; Issues related to small business retirement and retirement savings; Issues related to retirement savings for military spouses; SIMPLE IRAs; Issues related to financial transaction, capital gains, and dividend income taxes; Issues related to senior investor protection matters; Issues related to SEC and DOL standard of care rulemaking; Issues related to partnership tax and IRS Code Section 199A; Issues related to state and local tax provisions for Service Business in the One Big Beautiful Bill Act (PL 119-21).
Filing targets: SENATE
Issues related to tariffs and trade.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)
Issues related to data exclusivity under the United States Mexico Canada Agreement (USMCA); Issues regarding the World Trade Organization's TRIPS Waiver on COVID Vaccines; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the Medicaid Drug Rebate Program.
Issues pertaining to prescription drug pricing; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the Medicaid Drug Rebate Program.
Issues related to Direct to Consumer (DTC) Advertising; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the Medicaid Drug Rebate Program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to prescription drug pricing; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the 340b program.
Issues related to prescription drug pricing; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to pharmacy benefit managers; H.R. 1672 - Maintaining Investments in New Innovation Act; Issues related to the 340b program; Issues related to S. 832 - EPIC Act of 2025.
Issues related to prescription drug pricing and Intellectual Property (IP); Issues regarding the World Trade Organization's TRIPS Waiver on COVID Vaccines; Issues related to the 340b program.
Issues related to prescription drug pricing; Issues related to pharmaceutical intellectual property; Issues related to international trade; Issues related to the 340b program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to tax treatment of REITS (Real Estate Investment Trust).
Issues related to federal records management; Issues related to House Transportation and Infrastructure Committee Resolution regarding Prospectus PPA-FBC-BO17; Issues related to federal record storage; Issues related to federal records management for the VA.
Issues related to federal records management; Issues related to federal background checks.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to the report accompanying the FY 26 Senate Labor-HHS-Education Appropriations; Issues related to Rx drug pricing in the One Big Beautiful Bill Act (P.L. 119-21).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to funding of the strategic national stockpile; Issues related to the Tax Cuts and Jobs Act (PL 115-97); Issues related to the Medicaid Drug Rebate Program.
Issues related to international tax and R&D amortization credit in the Tax Cuts and Jobs Act (PL 115-97); Issues related to tax; Issues related to the implementation of the Tax Cuts and Jobs Act (PL 115-97); Issues related to the Medicaid Drug Rebate Program.
Issues regarding the Center for Medicare and Medicaid Innovation; Issues related to the implementation of the Tax Cuts and Jobs Act (PL 115-97); Issues related to the Medicaid Drug Rebate Program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to Veterans with ALS, access to ALS care, and appropriations funding.
Issues related to transportation and food delivery.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to workplace standards; Issues related to livestock and food pricing.
Issues related to livestock and food pricing.
Issues related to workplace standards; Issues related to livestock and food pricing; Issues related to labor union work condition negotiation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to Farm Bill Reauthorization; Issues related to the reintroduction of the Timber Innovation for Building Rural Communities Act (TIBRC) / 2026 Agriculture Appropriations; Issues related to Defense and Interior Appropriations; Issues related to extension of provisions in the Tax Cuts and Jobs Act (TCJA) (P.L. 115-97).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR), White House Office
Issues related to Department of Defense operations, including records management; Issues related to the implementation of the American Rescue Plan Act of 2021 (PL 117-2).
Issues related to federal records management; Issues related to House Transportation and Infrastructure Committee Resolution regarding Prospectus PPA-FBC-BO17; Issues related to federal record storage; Issues related to federal records management for the VA.
Issues related to federal records management; Issues related to federal background checks.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE